Surgical Science Sweden ABFRA:4P41 -3.89%86 Operating Margin % is 9.72% as of Mar. 2026, which is 36% below its 10-year median of 15.18. GuruFocus rates FRA:4P41 with a GF Score™ of 86/100 and a GF Value™ of €13.83 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Surgical Science Sweden AB ranks better than 60.03% on this metric.
Surgical Science Sweden AB operating margin has been in a 5-year decline. The average rate of decline per year is -12.9%.
The historical rank and industry rank for Surgical Science Sweden AB's Operating Margin % or its related term are showing as below:
FRA:4P41'
s Operating Margin % Range Over the Past 10 Years
Min: -7.31 Med: 15.18 Max: 21.43
Current: 6.95
FRA:4P41's Operating Margin % is ranked better than 60.03% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 4.845
vs FRA:4P41: 6.95
Surgical Science Sweden AB (FRA:4P41) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Surgical Science Sweden AB Operating Margin % Related Terms
Surgical Science Sweden AB Operating Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgical Science Sweden AB Operating Margin % Chart
FRA:4P41 vs VEEV, BTSG, TEM: Operating Margin % Comparison
For the Health Information Services subindustry, Surgical Science Sweden AB's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgical Science Sweden AB Operating Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Surgical Science Sweden AB's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Surgical Science Sweden AB's Operating Margin % falls into.
Surgical Science Sweden AB Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Surgical Science Sweden AB's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgical Science Sweden AB (FRA:4P41) has a Operating Margin % of 9.72% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Surgical Science Sweden AB and its competitors. This is 36% below median its historical median of 15.18. According to the industry distribution chart, Surgical Science Sweden AB ranks #267 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 40%.
Is Surgical Science Sweden AB's Operating Margin % too high?
Surgical Science Sweden AB's current Operating Margin % of 9.72% is 36% below median its 10-year median of 15.18. The Healthcare Providers & Services industry median Operating Margin % is 4.85. Surgical Science Sweden AB's value of 9.72% is 100.6% above this industry median. Based on the distribution chart, Surgical Science Sweden AB ranks #267 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Surgical Science Sweden AB has a GF Score™ of 86/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Surgical Science Sweden AB's Operating Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Surgical Science Sweden AB ranks #267 out of 668 companies for Operating Margin %. This puts Surgical Science Sweden AB in the upper half of its industry. The industry median Operating Margin % is 4.85. Surgical Science Sweden AB's value of 9.72% is 100.6% above this benchmark. While the company's 10-year median is 15.18 vs. the industry median of 4.85, Surgical Science Sweden AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Healthcare Providers & Services company?
The median Operating Margin % among Healthcare Providers & Services companies is 4.85, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgical Science Sweden AB's current Operating Margin % of 9.72% is 100.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Surgical Science Sweden AB and its competitors. For the Healthcare Providers & Services industry, the median Operating Margin % is 4.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgical Science Sweden AB's current Operating Margin % is 9.72%, which is 36% below median its own 10-year median of 15.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Science Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Surgical Science Sweden AB (FRA:4P41) is currently considered Significantly Undervalued. The stock's GF Value™ is €13.83, compared to a current price of €2.87 — trading 79.2% below its estimated fair value. The current Operating Margin % is 9.72%, which is 36% below median its 10-year median of 15.18 and 100.6% above the Healthcare Providers & Services industry median of 4.85. Surgical Science Sweden AB's overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Surgical Science Sweden AB (FRA:4P41), the current Operating Margin % is 9.72% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Surgical Science Sweden AB (FRA:4P41) Overvalued in 2026?
Based on GuruFocus' analysis, Surgical Science Sweden AB stock appears to be undervalued.
The current stock price of €2.87 is trading 79.2% below its estimated GF Value™ of €13.83.
GuruFocus considers Surgical Science Sweden AB to be Significantly Undervalued.
Key valuation signals for FRA:4P41:
Operating Margin %: 9.72% (36% below median its 10-year median of 15.18)
GF Value™: €13.83 vs. price of €2.87 (79.2% below fair value)
Industry Position: 100.6% above the Healthcare Providers & Services median (#267 of 668)
No single metric tells the full story. See the FRA:4P41 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments: Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations prior to entering the clinical environment, as well as support and services. Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments, and also simulators for medical device companies.
86GF Score
Get the complete analysis for FRA:4P41
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:4P41 has been successfully added to your 
